Several molecular mechanisms cause chemoresistance in tumor cells, comprising drug efflux and influx regulation via cell death suppression, the ATP-binding cassette transporter family, epigenetic factors, changes in drug absorption and metabolism, reduced functionality of the chemotherapeutic agents, mutations in the target of the drug, increased DNA repair, and shifts in growth factor signaling. This evidence concerns the gene ABCA4 and neoplasm.